We are live on ! Find out more
CANO.WS

Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150

Delisted

CANO.WS was delisted on the 9th of November, 2023.

27 hedge funds and large institutions have $3.18M invested in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% less funds holding

Funds holding: 3027 (-3)

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

93% less capital invested

Capital invested by funds: $45.9M → $3.18M (-$42.7M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
27
Holders Change
-3
Holders Change %
-10%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
6
Increased
4
Reduced
7
Closed
9
Calls
$637K
Puts
Net Calls
+$637K
Net Calls Change
-$6.49M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$7 +$29 +33 New
UFM
27
Ursa Fund Management
California
-$7.4M -2,804,246 Closed
LP
28
LMR Partners
United Kingdom
-$9.83M -1,133,723 Closed
DCM
29
Difesa Capital Management
New York
-$1.14M -432,148 Closed
Citadel Advisors
30
Citadel Advisors
Florida
-$918K -347,695 Closed
CCFM
31
Cohen & Co Financial Management
New York
-$792K -300,000 Closed
PFM
32
Privium Fund Management
Netherlands
-$471K -179,262 Closed
CCA
33
Castle Creek Arbitrage
Colorado
-$235K -89,845 Closed
SCM
34
Saba Capital Management
New York
-$56K -21,200 Closed
Parallax Volatility Advisers
35
Parallax Volatility Advisers
California
-$53K -20,000 Closed

CANO.WS Hedge Fund Activity: Q4 2022 in Review

27 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) for Q4 2022, worth a combined $3.18M — down 93% from $45.9M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of CANO.WS and 6 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 4 added.

The largest buyer was Zazove Associates, adding an estimated $3.95M. The largest seller was LMR Partners, exiting entirely with an estimated $9.83M sold.

  • 27 institutional investors held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) as of Q4 2022, down from 30 in Q3 2022.
  • Funds reported $3.18M of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 stock for Q4 2022, down 93% quarter-over-quarter.
  • 6 funds opened new Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 positions in Q4 2022 and 9 closed out, a net change of -3 holders.
  • The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 buyer in Q4 2022 was Zazove Associates, an estimated $3.95M added.
  • The largest Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 seller in Q4 2022 was LMR Partners, an estimated $9.83M sold.

Based on aggregated 13F filings for Q4 2022.